Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia

Clinical trial NCT00833976 · COMPLETED

Trial details

NCT number: NCT00833976
Sponsor: Massachusetts General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

High Triglycerides Hypercholesterolemia Schizophrenia Schizoaffective Disorder Bipolar Disorder

Start date: 2009-07-01
Primary completion: 2013-03-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.